Gel microcolumn assay (GMA) effectively identifies pregnancies at high risk for severe HDFN, but its false positivity rate ...

Umbilical cord blood (UCB) may offer a safe transfusion source for treating hemolytic disease of the fetus and newborn (HDFN) ...

If you have to travel to get your infant specialty care, you will likely benefit from planning ahead to avoid any unnecessary ...

Learn about the tests often performed on infants with HDFN, including what they measure and how many will be required.

Accurate detection of fetomaternal hemorrhage is essential to prevent hemolytic disease of the fetus and newborn (HDFN) in ...

Learn more about haptoglobin, including what it is, how it works and why infants with HDFN often have low haptoglobin levels.

A recent study found that an anti-Kell antibody level of eight can be used to reliably identify patients at risk of severe ...

The FDA approved Johnson & Johnson’s nipocalimab, which is also being studied as a potential treatment in HDFN, in myasthenia ...

Learn more about rebound hyperbilirubinemia in newborns, including its causes, symptoms and treatment options.

Nipocalimab, an emerging therapeutic agent for hemolytic disease of the fetus and newborn (HDFN), does not appear to affect ...

Integrating genetic data with immunological and blood testing can improve detection of HDFN due to ABO incompatibility, a ...